Cion Investment Corp
2 nominees · 2 ballot items.
Elect two Class II directors (Robert A. Breakstone and Catherine K. Choi) for three-year terms expiring in 2029; and ratify the selection of RSM US LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
Follow how the vote landed and what changed on Cion Investment Corp’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot2
- 1
Class II Director Proposal — Election of Two Directors
ManagementBoard: FORElect two directors, Robert A. Breakstone and Catherine K. Choi, each to serve three-year terms expiring in 2029 or until their successors are duly elected and qualified.
- 2
Auditors Proposal — Ratification of Independent Registered Public Accounting Firm
ManagementBoard: FORRatify the appointment of RSM US LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
Nominees on the ballot2
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | Bulldog Investors, LLPActivist | 3.1% | 1,538,071 | $11M |
| 2 | LPL Financial LLC | 2.0% | 989,153 | $7M |
| 3 | VAN ECK ASSOCIATES CORP | 1.9% | 968,155 | $7M |
| 4 | Private Advisor Group, LLC | 1.7% | 860,616 | $6M |
| 5 | Cambridge Investment Research Advisors, Inc. | 1.4% | 718,509 | $5M |
| 6 | UBS Group AG | 1.3% | 666,199 | $5M |
| 7 | MORGAN STANLEY | 1.3% | 636,599 | $4M |
| 8 | Invesco Ltd. | 1.2% | 617,425 | $4M |
| 9 | Callodine Capital Management, LP | 1.2% | 612,388 | $4M |
| 10 | Berger Financial Group, Inc | 0.8% | 406,899 | $3M |
Other Financial Services sector meetings6
Upcoming shareholder meetings at Cion Investment Corp’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Cion Investment Corp 2026 annual meeting?
- Cion Investment Corp (CION) holds its 2026 annual shareholder meeting on Thursday, June 25, 2026.
- What is the record date for the Cion Investment Corp 2026 meeting?
- The record date for the Cion Investment Corp 2026 meeting is Thursday, April 30, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Cion Investment Corp's 2026 meeting?
- The board is presenting 2 director nominees at the Cion Investment Corp 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Cion Investment Corp 2026 meeting?
- Shareholders will vote on 2 proposals at the Cion Investment Corp 2026 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.